Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
57 hedge funds and large institutions have $188M invested in Icosavax, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 20
12% less funds holding
Funds holding: 65 → 57 (-8)
16% less capital invested
Capital invested by funds: $223M → $188M (-$35.1M)
30% less call options, than puts
Call options by funds: $59K | Put options by funds: $84K
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.42M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.76M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.49M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
NanoDimension
Woodside,
California
|
-$7.47M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$3M |
| 3 |
PA
Perceptive Advisors
New York
|
-$2.62M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$664K |
| 5 |
Millennium Management
New York
|
-$476K |
ICVX Hedge Fund Activity: Q2 2022 in Review
57 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q2 2022, worth a combined $188M — down 16% from $223M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ICVX and 7 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 19 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $11.8M. The largest seller was NanoDimension, cutting an estimated $7.47M.
- 57 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q2 2022, down from 65 in Q1 2022.
- Funds reported $188M of Icosavax, Inc. Common Stock stock for Q2 2022, down 16% quarter-over-quarter.
- 7 funds opened new Icosavax, Inc. Common Stock positions in Q2 2022 and 14 closed out, a net change of -7 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q2 2022 was T. Rowe Price Associates, an estimated $11.8M added.
- The largest Icosavax, Inc. Common Stock seller in Q2 2022 was NanoDimension, an estimated $7.47M sold.
Based on aggregated 13F filings for Q2 2022.